The feto-placental unit stimulates the pregnancy-associated increase in maternal bone metabolism

O Ogueh1, G Khastgir, A Abbas

  • 1Section of Obstetrics and Gynaecology, Imperial College School of Medicine, Chelsea and Westminster Hospital, London, UK.

Insights

The feto-placental unit significantly impacts maternal bone metabolism during pregnancy. Increased fetal numbers stimulate bone resorption, a process reversible through fetal reduction.

Area of Science:

  • Reproductive Endocrinology
  • Bone Metabolism
  • Maternal-Fetal Medicine

Background:

  • Pregnancy significantly alters maternal bone metabolism.
  • The feto-placental unit's role in these changes is not fully understood.

Purpose of the Study:

  • To investigate the feto-placental unit's influence on pregnancy-induced maternal bone metabolism.
  • To assess bone formation and resorption markers in relation to fetal numbers.

Main Methods:

  • Measured serum concentrations of carboxy terminal pro-peptide of type I pro-collagen (PICP) and cross-linked carboxy terminal telopeptide of type I collagen (ICTP).
  • Studied singleton, twin, and multifetal pregnancies (≥3 fetuses) before and after selective fetal reduction.
  • Collected blood samples at 10-12 weeks gestation and 4 and 8 weeks post-reduction.

Main Results:

  • PICP and ICTP concentrations correlated positively with the number of fetuses.
  • Multifetal pregnancies showed significantly higher PICP and ICTP levels than twin pregnancies.
  • ICTP levels decreased to twin pregnancy levels post-fetal reduction, while PICP remained unchanged.

Conclusions:

  • The feto-placental unit releases a factor that stimulates maternal bone resorption, particularly in higher-order multiple pregnancies.
  • This factor's action is primarily on bone resorption, not formation.
  • Selective fetal reduction normalizes elevated bone resorption markers.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.